---
title: 'Meningioma: International Consortium on Meningiomas (ICOM) consensus review
  on scientific advances &amp; treatment paradigms for clinicians, researchers, and
  patients'
date: '2024-05-02'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38695575/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240502181207&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: Meningiomas are the most common primary intracranial tumors in adults
  and are increasing in incidence due to the aging population and the rising availability
  of neuroimaging. While most exhibit non-malignant behaviour, a subset of meningiomas
  are biologically aggressive and lead to significant neurological morbidity and mortality.
  In recent years, meaningful advances in our understanding of the biology of these
  tumors have led to the incorporation of molecular biomarkers into their grading
  ...
disable_comments: true
---
Meningiomas are the most common primary intracranial tumors in adults and are increasing in incidence due to the aging population and the rising availability of neuroimaging. While most exhibit non-malignant behaviour, a subset of meningiomas are biologically aggressive and lead to significant neurological morbidity and mortality. In recent years, meaningful advances in our understanding of the biology of these tumors have led to the incorporation of molecular biomarkers into their grading ...